News

Deal Announcements

Astute Medical Adds $2 Million Venture Capital Debt

Thursday, March 6, 2014 5:33:00 AM PDT | VentureDeal
   San Diego, California  --  Diagnostics firm Astute Medical has received in excess of $2 million in new venture capital debt funding, according to an SEC regulatory filing.

Astute is focused on identifying invalidating protein biomarkers of severe acute disease.

The company's products aim to speed up the diagnosis and risk assessment of community and hospital acquired acute conditions.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1